What Is Copper Storage Disease?
Copper is an essential trace mineral that the body uses for enzyme function, iron metabolism, and connective tissue formation. In healthy dogs, excess copper is excreted through bile into the intestinal tract and eliminated in faeces. In dogs with copper storage disease, this excretion mechanism is impaired, and copper accumulates within hepatocytes — the functional cells of the liver — over months and years, eventually causing significant damage.
The condition goes by several names: copper-associated hepatopathy, copper-associated chronic hepatitis, or simply copper storage disease. It is one of the more common causes of chronic liver disease in certain dog breeds and, when caught early, is highly manageable.
Which Breeds Are Affected?
Bedlington Terriers were the first breed in which a hereditary form of copper storage disease was clearly characterised. They carry a mutation affecting the COMMD1 gene (previously known as MURR1), which is responsible for copper transport out of liver cells. The disease follows an autosomal recessive inheritance pattern, meaning a dog must inherit two copies of the defective gene to develop the condition.
Since the identification of copper storage disease in Bedlington Terriers, similar — though not always genetically identical — conditions have been recognised in a growing number of breeds, including:
- Labrador Retrievers
- Dobermann Pinschers
- Dalmatians
- West Highland White Terriers
- Skye Terriers
- American and English Cocker Spaniels
In some of these breeds, the genetic basis is less well understood or involves different mutations. Environmental and dietary factors — including the copper content of commercial dog foods — may also contribute to the development or severity of copper accumulation.
How Does Copper Damage the Liver?
When copper builds up within hepatocytes, it generates reactive oxygen species through a process called Fenton chemistry. This oxidative stress damages cell membranes, mitochondria, and DNA. Initially, cells respond by sequestering copper in lysosomes, but this protective mechanism eventually becomes overwhelmed.
The result is a cycle of hepatocellular necrosis (cell death), inflammation, and fibrosis. Over time, the cumulative damage reduces the liver's functional capacity. In some dogs, particularly Bedlington Terriers, an acute haemolytic crisis can occur when large amounts of copper are suddenly released from dying liver cells into the bloodstream, destroying red blood cells.
Clinical Signs and When They Appear
Because copper accumulates gradually, affected dogs often appear entirely normal in the early and middle stages of disease. Clinical signs typically emerge only once liver damage is advanced, which is why breed-specific screening is so important.
When symptoms do appear, they mirror those of other forms of liver disease:
- Lethargy and exercise intolerance
- Reduced appetite and weight loss
- Vomiting
- Jaundice in more advanced cases
- Acute collapse or weakness in haemolytic crises
Blood tests typically reveal elevated liver enzymes, particularly ALT. In Bedlington Terriers, even mildly elevated ALT in a young dog should prompt further investigation rather than a wait-and-see approach.
Diagnosis
A definitive diagnosis requires a liver biopsy with quantitative copper measurement. Copper concentrations above 400 micrograms per gram of dry liver weight are generally considered abnormal, though this threshold is breed-dependent. Histochemical staining (commonly with rhodanine or rubeanic acid) can reveal copper deposits within hepatocytes and guide assessment of the pattern and severity of accumulation.
In Bedlington Terriers specifically, a genetic DNA test is available and widely used by responsible breeders. Dogs can be tested as puppies and classified as clear, carrier, or affected. This has allowed significant progress in reducing the prevalence of the disease within the breed. Responsible breeding programmes now routinely test before mating.
Treatment: Chelation Therapy
The cornerstone of treatment for dogs with established copper accumulation is chelation therapy — the use of agents that bind to copper and facilitate its removal from the body.
D-penicillamine
D-penicillamine is the most commonly used chelator in veterinary medicine. It binds to copper and promotes its urinary excretion. It is generally given twice daily on an empty stomach. Nausea and vomiting are the most common side effects; giving a small amount of food beforehand, or splitting the dose differently, can help manage this.
Trientine
Trientine (triethylene tetramine) is an alternative chelator used when D-penicillamine is not tolerated. It is less readily available but similarly effective at reducing hepatic copper levels.
Chelation therapy typically continues for several months, with liver biopsy repeated to monitor progress. Enzyme normalisation alone is not sufficient evidence that copper levels have fallen to safe levels.
The Role of Diet
Dietary management is an important adjunct to — not a replacement for — medical therapy. The aim is to reduce copper intake from food while ensuring complete and balanced nutrition.
Copper-Restricted Diets
Prescription hepatic diets formulated for dogs with liver disease typically contain restricted copper levels. They also tend to use copper sources (such as copper sulphate versus copper chelates) that differ in bioavailability. Home-prepared diets can be useful in highly copper-sensitive dogs but must be formulated by a veterinary nutritionist to avoid creating other deficiencies.
Foods to Limit
- Organ meats, particularly liver and kidney, are very high in copper and should be avoided
- Shellfish, especially oysters, are extremely copper-dense
- Some whole grains and legumes contain moderate copper and may warrant reduction
Zinc Supplementation
Zinc competes with copper for intestinal absorption. Supplementing zinc at appropriate levels can help reduce ongoing copper uptake from the diet. It is most effective as a maintenance strategy once copper levels have been brought down through chelation, rather than as an initial treatment for severe accumulation.
Antioxidant Support
Given the oxidative stress central to copper-induced damage, antioxidant supplementation is a reasonable adjunct. Vitamin E is most commonly recommended, and SAMe (S-adenosylmethionine) also has antioxidant and hepatoprotective properties. These do not replace medical treatment but may support recovery and reduce ongoing cellular damage.
Prognosis and Monitoring
Dogs diagnosed before significant fibrosis has developed generally have a good long-term prognosis. Regular monitoring — including liver enzyme panels every three to six months and periodic biopsies — is necessary to track progress and adjust treatment. With consistent management, many dogs live normal life spans with excellent quality of life.